Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

170 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP. Then Bergh F, et al. Among authors: daumer m. BMC Neurol. 2006 May 23;6:19. doi: 10.1186/1471-2377-6-19. BMC Neurol. 2006. PMID: 16719908 Free PMC article. Clinical Trial.
MRI as an outcome in multiple sclerosis clinical trials.
Sormani MP, Filippi M, De Stefano N; MAGNIMS Steering Committee; Ebers G, Daumer M. Sormani MP, et al. Among authors: daumer m. Neurology. 2009 Dec 1;73(22):1932; author reply 1932-3. doi: 10.1212/WNL.0b013e3181bd6b8f. Neurology. 2009. PMID: 19949043 No abstract available.
MRI as an outcome in multiple sclerosis clinical trials.
Daumer M, Neuhaus A, Morrissey S, Hintzen R, Ebers GC. Daumer M, et al. Neurology. 2009 Feb 24;72(8):705-11. doi: 10.1212/01.wnl.0000336916.38629.43. Epub 2008 Dec 10. Neurology. 2009. PMID: 19073945
Survival, and time to an advanced disease state or progression, of untreated patients with moderately severe multiple sclerosis in a multicenter observational database: relevance for design of a clinical trial for high dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation.
Daumer M, Griffith LM, Meister W, Nash RA, Wolinsky JS. Daumer M, et al. Mult Scler. 2006 Apr;12(2):174-9. doi: 10.1191/135248506ms1256oa. Mult Scler. 2006. PMID: 16629420
Disability as an outcome in MS clinical trials.
Ebers GC, Heigenhauser L, Daumer M, Lederer C, Noseworthy JH. Ebers GC, et al. Among authors: daumer m. Neurology. 2008 Aug 26;71(9):624-31. doi: 10.1212/01.wnl.0000313034.46883.16. Epub 2008 May 14. Neurology. 2008. PMID: 18480462
170 results